Bay 41-4109 racemate

• CAT Number: I013753
• CAS Number: 298708-79-9
• Molecular Formula: C₁₈H₁₃ClF₃N₃O₂
• Molecular Weight: 395.76
• Purity: ≥95%
• Target: HBV
• Solubility: DMSO: ≥ 37 mg/mL
• Storage: -20°C
• IUPAC Name: methyl 4-(2-chloro-4-fluorophenyl)-2-(3,5-difluoropyridin-2-yl)-6-methyl-1,4-dihydropyrimidine-5-carboxylate
• InChI: InChI=1S/C18H13ClF3N3O2/c1-8-14(18(26)27-2)15(11-4-3-9(20)5-12(11)19)25-17(24-8)16-13(22)6-10(21)7-23-16/h3-7,15H,1-2H3,(H,24,25)
• InChIKey: FVNJBPMQWSIGJK-UHFFFAOYSA-N
• SMILES: CC1=C(C(N=C(N1)C2=C(C=C(C=N2)F)F)C3=C(C=C(C=C3)F)Cl)C(=O)OC

BAY 41-4109 racemate（Cat No.:I013753）, also known as BAY41-4109 Racemic, is a mixture of the R-isomer and the S-isomer of BAY 41-4109. BAY 41-4109 is an antiviral compound that demonstrates inhibitory activity against human hepatitis B virus (HBV). It exhibits an IC50 (half-maximal inhibitory concentration) of 53 nM, indicating its potency in suppressing HBV replication. The compound holds promise as a potential therapeutic agent for the treatment of HBV infections, and further research is underway to explore its efficacy, safety, and potential clinical applications.

Reference

[1]. Weber O, et al. Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model. Antiviral Res. 2002 May;54(2):69-78.[2]. Stray SJ, et al. BAY 41-4109 has multiple effects on Hepatitis B virus capsid assembly. J Mol Recognit. 2006 Nov-Dec;19(6):542-8.[3]. Wu GY, et al. Inhibition of hepatitis B virus replication by Bay 41-4109 and its association with nucleocapsid disassembly. J Chemother. 2008 Aug;20(4):458-67.